Drug Enforcement Administration April 2014 – Federal Register Recent Federal Regulation Documents

Ten synthetic cathinones: 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP); alpha- pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2- (methylamino)butan-1-one (butylone); 2-(methylamino)-1-phenylpentan-1- one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone); 4-fluoro-N-methylcathinone (4-FMC); 3-fluoro-N- methylcathinone (3-FMC); naphthylpyrovalerone (naphyrone); and alpha- pyrrolidinobutiophenone ([alpha]-PBP) were temporarily placed in schedule I of the Controlled Substances Act (CSA) by a final order published by the Drug Enforcement Administration (DEA) on March 7, 2014 (79 FR 12938). This means that any manufacturer that wishes to manufacture 4-MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, or [alpha]-PBP after March 7, 2014, must be registered with the DEA and have obtained a manufacturing quota for 4-MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4- FMC, 3-FMC, naphyrone, or [alpha]-PBP pursuant to 21 CFR part 1303. The DEA cannot issue individual manufacturing quotas for 4-MEC, 4- MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, or [alpha]-PBP unless and until it establishes an aggregate production quota. Therefore, this notice proposes a 2014 aggregate production quota for 4-MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3-FMC, naphyrone, and [alpha]-PBP.